• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸入性微纳米颗粒的巨噬细胞清除作用研究进展。

Update on macrophage clearance of inhaled micro- and nanoparticles.

机构信息

Institute of Anatomy, University of Bern, Bern, Switzerland.

出版信息

J Aerosol Med Pulm Drug Deliv. 2010 Aug;23(4):207-17. doi: 10.1089/jamp.2009.0797.

DOI:10.1089/jamp.2009.0797
PMID:20109124
Abstract

BACKGROUND

Lung macrophages, that is, the intravascular, interstitial, pleural, and surface macrophages, are part of the mononuclear phagocyte system. They are derived from the hematopoietic stem cell in the bone marrow with the monocytes as their putative precursors. Macrophages residing on the inner surfaces of the lungs and immersed within the lung lining layer, that is, the alveolar and the airway macrophages, are constantly exposed to the environment; it is those cells that are recognized as first line of cellular host defense.

METHODS AND RESULTS

Phagocytic uptake of inhaled and deposited particles is the main mechanism to remove insoluble micrometer-sized particles from the lung surfaces, where mucociliary transport, cough, or sneezing fail or are absent. Phagocytosis requires an intact cytoskeleton and is most efficient when mediated by Fc-receptors, but complement and scavenger receptors like MARCO and CD206 are just as important. The main pathway for the clearance of macrophage-associated particles is by mucociliary transport; to a lesser degree and species specific, particle-containing macrophages may reenter into the interstitium and go from there to the lymphatics. Inhaled nanometer-sized particles that deposit along the entire respiratory tract, however, are not efficiently phagocytosed by surface macrophages.

CONCLUSIONS

Uptake by spontaneous or stimulated (macro-) pinocytosis or electrokinetic's phenomena may become more important. In addition, translocation of nanometer-sized particles into the interstitium and to the blood circulation brings them into contact with other fluids; altered particle properties may influence particle uptake. Moreover, translocated particles may interact with lung macrophage populations that were previously not considered of great significance for the clearance of inhaled particles.

摘要

背景

肺巨噬细胞,即血管内、间质、胸膜和表面巨噬细胞,是单核吞噬细胞系统的一部分。它们来源于骨髓中的造血干细胞,单核细胞是其潜在前体。驻留在肺内表面并沉浸在肺衬里层中的巨噬细胞,即肺泡和气道巨噬细胞,不断暴露于环境中;正是这些细胞被认为是细胞宿主防御的第一道防线。

方法和结果

吞噬作用是从肺表面清除不可溶性微米大小颗粒的主要机制,在那里,黏液纤毛转运、咳嗽或打喷嚏失败或不存在。吞噬作用需要完整的细胞骨架,并且当由 Fc 受体介导时效率最高,但补体和清道夫受体(如 MARCO 和 CD206)同样重要。清除与巨噬细胞相关的颗粒的主要途径是通过黏液纤毛转运;在较小程度上和物种特异性上,含颗粒的巨噬细胞可能重新进入间质,并从那里进入淋巴管。然而,沿整个呼吸道沉积的纳米大小的颗粒不能被表面巨噬细胞有效吞噬。

结论

自发或刺激(大)胞饮作用或电动现象的摄取可能变得更为重要。此外,纳米大小的颗粒向间质和血液循环中的转移使它们与其他液体接触;改变颗粒的性质可能会影响颗粒的摄取。此外,转移的颗粒可能与以前被认为对吸入颗粒清除作用不重要的肺巨噬细胞群体相互作用。

相似文献

1
Update on macrophage clearance of inhaled micro- and nanoparticles.吸入性微纳米颗粒的巨噬细胞清除作用研究进展。
J Aerosol Med Pulm Drug Deliv. 2010 Aug;23(4):207-17. doi: 10.1089/jamp.2009.0797.
2
Barriers that Inhaled Particles Encounter.吸入颗粒所遇到的障碍。
J Aerosol Med Pulm Drug Deliv. 2024 Oct;37(5):299-306. doi: 10.1089/jamp.2024.27498.bp.
3
Role of alveolar macrophage chemotaxis and phagocytosis in pulmonary clearance responses to inhaled particles: comparisons among rodent species.肺泡巨噬细胞趋化性和吞噬作用在肺部对吸入颗粒清除反应中的作用:啮齿动物物种间的比较
Microsc Res Tech. 1993 Dec 1;26(5):412-22. doi: 10.1002/jemt.1070260509.
4
The role of macrophages in the clearance of inhaled ultrafine titanium dioxide particles.巨噬细胞在清除吸入的超细二氧化钛颗粒中的作用。
Am J Respir Cell Mol Biol. 2008 Mar;38(3):371-6. doi: 10.1165/rcmb.2007-0138OC. Epub 2007 Oct 18.
5
Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles.颗粒参数在评估吸入颗粒暴露-剂量-反应关系中的意义
Inhal Toxicol. 1996;8 Suppl:73-89.
6
Morphological aspects of particle uptake by lung phagocytes.肺吞噬细胞摄取颗粒的形态学方面。
Microsc Res Tech. 2002 Jun 15;57(6):512-22. doi: 10.1002/jemt.10105.
7
The effect of particle inhalation on macrophage number and phagocytic activity in the intrapulmonary conducting airways of hamsters.
Am J Respir Cell Mol Biol. 1994 Jun;10(6):594-603. doi: 10.1165/ajrcmb.10.6.8003338.
8
Inhalation of high concentrations of low toxicity dusts in rats results in impaired pulmonary clearance mechanisms and persistent inflammation.在大鼠中吸入高浓度低毒性粉尘会导致肺部清除机制受损和持续性炎症。
Toxicol Appl Pharmacol. 1997 Jul;145(1):10-22. doi: 10.1006/taap.1997.8102.
9
Mathematical modeling of the retention and clearance of low-toxicity particles in the lung.低毒性颗粒在肺内滞留与清除的数学建模
Inhal Toxicol. 1999 Dec;11(12):1059-76. doi: 10.1080/089583799196592.
10
In vivo comparison of cat alveolar and pulmonary intravascular macrophages: phagocytosis, particle clearance, and cytoplasmic motility.猫肺泡巨噬细胞与肺血管内巨噬细胞的体内比较:吞噬作用、颗粒清除及细胞质运动
Exp Lung Res. 2007 Mar;33(2):53-70. doi: 10.1080/01902140701198542.

引用本文的文献

1
Gelatin-Based Microspheres of Ciprofloxacin for Enhanced Lung Delivery and Biofilm Eradication in Pulmonary Infections.用于增强肺部给药及根除肺部感染中生物膜的环丙沙星明胶基微球
Gels. 2025 Jul 23;11(8):567. doi: 10.3390/gels11080567.
2
Spore-inspired inhalation drug delivery system for asthma therapy.用于哮喘治疗的受孢子启发的吸入式药物递送系统。
Bioact Mater. 2025 Aug 6;53:801-818. doi: 10.1016/j.bioactmat.2025.07.045. eCollection 2025 Nov.
3
Inhalable nanoparticle-based delivery systems for the treatment of pulmonary infections: and barrier-overcoming strategies.
用于治疗肺部感染的基于可吸入纳米颗粒的递送系统及克服屏障的策略。
Drug Deliv. 2025 Dec;32(1):2544683. doi: 10.1080/10717544.2025.2544683. Epub 2025 Aug 11.
4
Biopersistence of man-made vitreous fibres (MMVF) / synthetic vitreous fibres (SVF): advancing from animal models to acellular testing.人造玻璃纤维(MMVF)/合成玻璃纤维(SVF)的生物持久性:从动物模型到无细胞测试的进展
Part Fibre Toxicol. 2025 Jul 11;22(1):19. doi: 10.1186/s12989-025-00636-7.
5
Application of in vitro pulmonary models for hazard screening of silica particles.体外肺模型在二氧化硅颗粒危害筛查中的应用。
Arch Toxicol. 2025 Jun 25. doi: 10.1007/s00204-025-04100-5.
6
Design, optimization, and evaluation of lyophilized lipid nanoparticles for mRNA-based pulmonary mucosal vaccination.基于mRNA的肺部黏膜疫苗冻干脂质纳米颗粒的设计、优化与评价
Mater Today Bio. 2025 May 4;32:101813. doi: 10.1016/j.mtbio.2025.101813. eCollection 2025 Jun.
7
iBCS: 4. Application of the Inhalation Biopharmaceutics Classification System to the Development of Orally Inhaled Drug Products.吸入生物药剂学分类系统:4. 吸入生物药剂学分类系统在口服吸入制剂研发中的应用。
Mol Pharm. 2025 Apr 7;22(4):1740-1751. doi: 10.1021/acs.molpharmaceut.4c01534. Epub 2025 Mar 13.
8
Nanomedicine Innovations for Lung Cancer Diagnosis and Therapy.肺癌诊断与治疗的纳米医学创新
ACS Appl Mater Interfaces. 2025 Mar 5;17(9):13197-13220. doi: 10.1021/acsami.4c16840. Epub 2024 Dec 30.
9
Comparative toxicity study of three surface-modified titanium dioxide nanoparticles following subacute inhalation.三种表面改性二氧化钛纳米颗粒亚急性吸入后的比较毒性研究
Part Fibre Toxicol. 2025 Feb 24;22(1):5. doi: 10.1186/s12989-025-00620-1.
10
Enhanced Macrophage Uptake of Spray-Dried Phosphatidylserine-Loaded Microparticles for Pulmonary Drug Delivery Applications.用于肺部给药应用的喷雾干燥载磷脂酰丝氨酸微粒的巨噬细胞摄取增强
J Drug Deliv Sci Technol. 2025 Feb;104. doi: 10.1016/j.jddst.2024.106535. Epub 2024 Dec 13.